The invention relates to the compounds of ##STR00001##
related compounds, or pharmaceutically acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I, and methods for the treatment of mucositis may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be used to treatment of mucus diseases related to painful inflammation and ulceration of the digestive tract lining and in the mouth.

The invention relates to the compounds of ##STR00001##
related compounds, or pharmaceutically acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I, and methods for the treatment of mucositis may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be used to treatment of mucus diseases related to painful inflammation and ulceration of the digestive tract lining and in the mouth.

The present disclosure provides a quantum dot ligand and a method for preparing the same, a light emitting device and a method for preparing the same, and a display device. The quantum dot ligand is an azobenzene compound represented by formula (I). The azobenzene compound in the quantum dot ligand of the present disclosure has at least one group on each benzene ring, and the groups on the benzene rings of the azobenzene compound can be connected to the quantum dot through a coordination bond, thereby forming a network or chain structure.

The present disclosure provides a quantum dot ligand and a method for preparing the same, a light emitting device and a method for preparing the same, and a display device. The quantum dot ligand is an azobenzene compound represented by formula (I). The azobenzene compound in the quantum dot ligand of the present disclosure has at least one group on each benzene ring, and the groups on the benzene rings of the azobenzene compound can be connected to the quantum dot through a coordination bond, thereby forming a network or chain structure.

Provided herein are a use of thioether compounds of formula I as nitrification inhibitors, and agricultural mixtures and compositions including the thioether compounds.

Provided herein are a use of thioether compounds of formula I as nitrification inhibitors, and agricultural mixtures and compositions including the thioether compounds.

Process for the preparation of azidoperfluoroalkanes and azidopolyfluoroalkanes of general formula R.sub.FN.sub.3, where R.sub.F is chosen from a group containing C.sub.nF.sub.2n+1, C.sub.nF.sub.xH.sub.2n+1x, C.sub.nF.sub.xX.sub.2n+1x or R.sup.1CF.sub.2CF.sub.2, where n is an integer in the range of 1 to 10, x is an integer in the range of 2 to 20, X is Cl, Br, or I, R.sup.1 is C.sub.1-10 alkyl, ArO, ArS, imidazolyl, benzimidazolyl, or pyrazolyl and Ar is phenyl or substituted phenyl, by the reaction of electrophilic azidation reagent of general formula R.sup.2N.sub.3, where R.sup.2 is n-C.sub.4F.sub.9SO.sub.2, ArSO.sub.2, Br, I, with synthetic equivalent of polyfluoroalkylated carbanion of general formula [R.sub.F].sup..

Process for the preparation of azidoperfluoroalkanes and azidopolyfluoroalkanes of general formula R.sub.FN.sub.3, where R.sub.F is chosen from a group containing C.sub.nF.sub.2n+1, C.sub.nF.sub.xH.sub.2n+1x, C.sub.nF.sub.xX.sub.2n+1x or R.sup.1CF.sub.2CF.sub.2, where n is an integer in the range of 1 to 10, x is an integer in the range of 2 to 20, X is Cl, Br, or I, R.sup.1 is C.sub.1-10 alkyl, ArO, ArS, imidazolyl, benzimidazolyl, or pyrazolyl and Ar is phenyl or substituted phenyl, by the reaction of electrophilic azidation reagent of general formula R.sup.2N.sub.3, where R.sup.2 is n-C.sub.4F.sub.9SO.sub.2, ArSO.sub.2, Br, I, with synthetic equivalent of polyfluoroalkylated carbanion of general formula [R.sub.F].sup..

The present invention relates to intermediates of Formula I ##STR00001##
and to methods of synthesizing and purifying calicheamicin derivatives.

The present invention relates to intermediates of Formula I ##STR00001##
and to methods of synthesizing and purifying calicheamicin derivatives.